These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7097721)

  • 1. Structure-activity correlations of cytochalasins. Novel halogenated and related cytochalasin C and D derivatives.
    Patwardhan BH; Flashner M; Miller CA; Tanenbaum SW
    J Med Chem; 1982 Jun; 25(6):663-6. PubMed ID: 7097721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the conjugated carbonyl of cytochalasin A in contractility inhibitions.
    Tanenbaum SW; Patwardhan BH; Haynes L; Flashner M
    Life Sci; 1982 May; 30(22):1927-31. PubMed ID: 7109829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cytochalasins on F-actin and morphology of Ehrlich ascites tumor cells.
    Mills JW; Falsig Pedersen S; Walmod PS; Hoffmann EK
    Exp Cell Res; 2000 Nov; 261(1):209-19. PubMed ID: 11082291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversely Functionalised Cytochalasins through Mutasynthesis and Semi-Synthesis.
    Wang C; Lambert C; Hauser M; Deuschmann A; Zeilinger C; Rottner K; Stradal TEB; Stadler M; Skellam EJ; Cox RJ
    Chemistry; 2020 Oct; 26(60):13578-13583. PubMed ID: 32484589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerated doses in zebrafish of cytochalasins and jasplakinolide for comparison with tolerated doses in mice in the evaluation of pre-clinical activity of microfilament-directed agents in tumor model systems in vivo.
    Trendowski M; Wong V; Wellington K; Hatfield S; Fondy TP
    In Vivo; 2014; 28(6):1021-31. PubMed ID: 25398795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy with cytochalasin congeners in vitro and in vivo against murine models.
    Trendowski M; Mitchell JM; Corsette CM; Acquafondata C; Fondy TP
    Invest New Drugs; 2015 Apr; 33(2):290-9. PubMed ID: 25563824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of cytochalasins on the surface topography of neoplastic cells in suspension].
    Allikmets EIu; Vasil'ev IuM; Rovenskiĭ IuA
    Biull Eksp Biol Med; 1983 May; 95(5):84-7. PubMed ID: 6850096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochalasin B binding to Ehrlich ascites tumor cells and its relationship to glucose carrier.
    Cuppoletti J; Mayhew E; Jung CY
    Biochim Biophys Acta; 1981 Apr; 642(2):392-404. PubMed ID: 7284364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro.
    Trendowski M; Christen TD; Acquafondata C; Fondy TP
    BMC Cancer; 2015 Sep; 15():632. PubMed ID: 26357852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cytochalasins on surfactant release from alveolar type II cells.
    Rice WR; Osterhoudt KC; Whitsett JA
    Biochim Biophys Acta; 1984 Sep; 805(1):12-8. PubMed ID: 6541060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of virus-induced fusion of Ehrlich ascites tumor cells by cytochalasin B and D.
    Asano A; Okada Y
    Life Sci; 1977 Jan; 20(1):117-22. PubMed ID: 189147
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro growth inhibitory effects of cytochalasins and derivatives in cancer cells.
    Van Goietsenoven G; Mathieu V; Andolfi A; Cimmino A; Lefranc F; Kiss R; Evidente A
    Planta Med; 2011 May; 77(7):711-7. PubMed ID: 21058241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of a series of sulfone analogues of 1,4-naphthoquinone.
    Holshouser MH; Loeffler LJ; Hall IH
    J Med Chem; 1981 Jul; 24(7):853-8. PubMed ID: 7277393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cytochalasins from medicinal macrofungus Crodyceps taii and their inhibitory activities against human cancer cells.
    Li XG; Pan WD; Lou HY; Liu RM; Xiao JH; Zhong JJ
    Bioorg Med Chem Lett; 2015 May; 25(9):1823-6. PubMed ID: 25863432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin assembly activity of cytochalasins and cytochalasin analogs assayed using fluorescence photobleaching recovery.
    Walling EA; Krafft GA; Ware BR
    Arch Biochem Biophys; 1988 Jul; 264(1):321-32. PubMed ID: 3395126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible antineoplastic agents, part 15: synthesis, biological activity and quantitative structure activity relationship of substituted-2-(4'-methoxybenzenesulphonamido) glutaric acid analogs against Ehrlich ascites carcinoma.
    Goswami D; Sen S; De AU
    Pharmazie; 2001 May; 56(5):366-71. PubMed ID: 11400550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enantioselective, modular, and general route to the cytochalasins: synthesis of L-696,474 and cytochalasin B.
    Haidle AM; Myers AG
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12048-53. PubMed ID: 15208404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluation of the effects of cytochalasins on steroidogenesis: studies on hamster granulosa cells.
    Silavin SL; Javitt NB; Strauss JF
    Endocrinology; 1984 Oct; 115(4):1511-6. PubMed ID: 6592092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for selective sulfhydryl reactivity in cytochalasin A--mediated bacterial inhibitions.
    Cunningham D; Flashner M; Tanenbaum SW
    Biochem Biophys Res Commun; 1979 Jan; 86(1):173-9. PubMed ID: 435298
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between effects of 24 different cytochalasins on cellular structures and cellular events and those on actin in vitro.
    Yahara I; Harada F; Sekita S; Yoshihira K; Natori S
    J Cell Biol; 1982 Jan; 92(1):69-78. PubMed ID: 7199054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.